期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 201, 期 3, 页码 568-572出版社
WILEY
DOI: 10.1111/bjh.18709
关键词
acute myeloid leukaemia; DAV; efficacy; safety; venetoclax